New randomized, controlled NIH supported clinical trial has begun to assess the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with COVID-19.
Scientists are hopeful that a new drug named EIDD-2801 could change the way doctors treat patients with COVID-19.
University of Oxford researchers have sought over 500 healthy volunteers to test the efficacy of their vaccine, ChAdOx1 nCoV-19, against coronavirus.